AKI - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced renal perfusion - This often results from hypotension or hypovolemia, leading to decreased blood flow to the kidneys and reduced glomerular filtration rate (GFR), impairing the kidneys' ability to filter waste and balance fluids.

• Secondary mechanism: Tubular injury - Ischemia or toxins can damage renal tubular cells, leading to acute tubular necrosis. This disrupts normal reabsorption and secretion processes, further decreasing GFR and causing accumulation of waste products in the blood.

• Key complication: Electrolyte imbalance - As kidney function declines, the regulation of electrolytes is impaired, leading to imbalances such as hyperkalemia, which can cause serious cardiac complications if not managed promptly.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, type 2 diabetes, chronic kidney disease stage 2

• Current medications: Lisinopril, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and swelling in the legs

• Key symptoms: Fatigue, nausea, shortness of breath, confusion

• Vital signs: Blood pressure 160/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C, oxygen saturation 91% on room air

Section 1

New Diagnostic Results:

After the initial assessment, the medical team decided to conduct a series of diagnostic tests to further evaluate the patient's condition. Blood tests revealed significant elevations in blood urea nitrogen (BUN) and creatinine levels, consistent with acute kidney injury (AKI), with BUN at 48 mg/dL and creatinine at 3.2 mg/dL. Electrolyte analysis showed hyperkalemia with a potassium level of 6.2 mEq/L, posing an immediate risk for cardiac complications. Additionally, the patient’s sodium level was slightly low at 132 mEq/L, indicating hyponatremia, likely secondary to fluid overload and impaired renal excretion.

A urinalysis indicated the presence of granular casts, which are suggestive of acute tubular necrosis. The fractional excretion of sodium (FENa) was calculated at over 2%, further supporting the diagnosis of intrinsic renal injury. An ECG was performed due to the elevated potassium levels and showed peaked T waves, a classic sign of hyperkalemia, necessitating urgent intervention to prevent arrhythmias.

These findings indicate that the patient's renal function has deteriorated significantly, likely due to a combination of his pre-existing chronic kidney disease, uncontrolled hypertension, and possibly exacerbated by his current medications. The immediate concern is the correction of the electrolyte imbalance, particularly hyperkalemia, to stabilize cardiac function. This will require a coordinated approach involving medication adjustments, possible dialysis consultation, and careful monitoring of fluid status and electrolytes. The clinical team must now prioritize these interventions to prevent further complications and consider the need for changes in the patient's long-term management plan to address underlying issues such as hypertension and diabetic control.

Section 2

Change in Patient Status:

Following the initiation of treatment for hyperkalemia, which included the administration of intravenous calcium gluconate to stabilize cardiac membranes and insulin with dextrose to facilitate the shift of potassium into cells, the patient's electrocardiogram showed a normalization of the T waves. However, despite these initial improvements, the patient's overall condition began to decline. He developed increasing respiratory distress, characterized by a respiratory rate of 28 breaths per minute and use of accessory muscles, indicating worsening fluid overload. Auscultation revealed bilateral crackles in the lung bases, and his oxygen saturation dropped to 88% on room air, necessitating supplemental oxygen to maintain adequate oxygenation.

Concurrently, the patient's blood pressure, which had initially been stable, began to fluctuate, with readings of 170/100 mmHg, likely exacerbated by fluid retention and autonomic instability due to uremic toxins. Repeat laboratory tests showed persistently elevated BUN and creatinine levels, with BUN now at 52 mg/dL and creatinine at 3.8 mg/dL, indicating ongoing renal impairment. Additionally, the patient's mental status started to decline, with increased lethargy and intermittent confusion, suggesting the development of uremic encephalopathy.

Given these developments, the clinical team faced the critical decision of initiating renal replacement therapy. A nephrology consult was urgently requested to evaluate the need for dialysis, as conservative measures were no longer sufficient to manage the patient's fluid overload and electrolyte imbalances. Furthermore, the team considered the need for adjustments to the patient's antihypertensive regimen and closer monitoring of his neurologic status, with the goal of stabilizing his condition and preventing further complications. This situation underscores the complexity of managing acute kidney injury in the context of chronic comorbidities and highlights the necessity for rapid, coordinated intervention to address the multifaceted challenges presented by the patient's deteriorating status.

Section 3

New Diagnostic Results:

Following the nephrology consult, the clinical team proceeded with additional diagnostic tests to gain a comprehensive understanding of the patient's condition. A chest X-ray was performed, which revealed bilateral pulmonary edema consistent with the patient's worsening respiratory status. This finding confirmed significant fluid overload, likely due to inadequate renal clearance. An echocardiogram was also conducted, showing preserved ejection fraction but evidence of diastolic dysfunction, suggesting that the fluid overload was predominantly due to renal impairment rather than cardiac failure. These results reinforced the need for renal replacement therapy to effectively manage the fluid imbalance and prevent further respiratory compromise.

Laboratory investigations provided further insights into the patient's metabolic status. There was a notable metabolic acidosis, with arterial blood gas analysis revealing a pH of 7.28 and a bicarbonate level of 18 mEq/L, indicating a significant acid-base disturbance likely exacerbated by the patient's acute kidney injury. Additionally, the patient's serum electrolytes showed persistent hyperkalemia with a potassium level of 5.8 mEq/L, despite initial interventions, and mild hypocalcemia with a calcium level of 8.2 mg/dL. These laboratory findings underscored the necessity for urgent intervention to correct the electrolyte imbalances and mitigate the risk of cardiac complications.

The nephrology team recommended initiating hemodialysis to address the severe fluid overload, persistent metabolic acidosis, and refractory hyperkalemia. The plan included close monitoring of the patient's hemodynamic status during dialysis to manage potential fluctuations in blood pressure and prevent further neurological deterioration. This decision was communicated to the patient's family, emphasizing the critical role of dialysis in stabilizing the patient's condition and preventing further progression of renal failure. The healthcare team prepared for the procedure, highlighting the need for interdisciplinary collaboration to ensure the patient's safety and optimize outcomes.

Section 4

As hemodialysis was initiated, the patient's initial response appeared promising, with gradual improvement in respiratory status and a decrease in bilateral pulmonary edema, as evidenced by improved breath sounds and reduced work of breathing. Vital signs showed a stable blood pressure at 110/70 mmHg and a heart rate of 88 beats per minute. However, during the second dialysis session, the patient exhibited a sudden change in neurological status, including confusion and disorientation. This raised concerns about possible dialysis disequilibrium syndrome, a complication characterized by cerebral edema resulting from rapid changes in serum osmolality.

Further laboratory analysis revealed a rapid decrease in serum urea levels from 150 mg/dL to 80 mg/dL, suggesting an aggressive reduction that may have contributed to the neurological symptoms. The patient's serum sodium, initially at 136 mEq/L, dropped to 130 mEq/L, indicating a possible disturbance in osmotic balance. The healthcare team promptly adjusted the dialysis prescription, opting for a slower rate of solute removal and an increased sodium concentration in the dialysate to mitigate further neurological complications.

Additionally, the patient's persistent hyperkalemia improved moderately with a current level of 5.2 mEq/L, but further management was deemed necessary to ensure continued stabilization. The team also monitored the mild hypocalcemia, now at 8.0 mg/dL, and initiated a calcium supplement to support electrolyte balance. The patient's family was updated on the developments, with a focus on the importance of careful hemodynamic and neurological monitoring during subsequent dialysis sessions. This approach aimed to prevent further complications while facilitating gradual improvement in the patient's renal function and overall stability.

Section 5

As the healthcare team continued to closely monitor the patient following the adjustments to the dialysis protocol, they observed a change in the patient's status that warranted further investigation. During a routine assessment, the patient began to exhibit increased fatigue accompanied by mild tachypnea, with a respiratory rate of 24 breaths per minute. Although the patient's blood pressure remained stable at 108/72 mmHg, and heart rate was consistent at 90 beats per minute, there was a noticeable pallor and slight peripheral cyanosis. Auscultation revealed faint crackles at the lung bases, suggesting that while pulmonary edema had initially improved, there might be a recurrence or another underlying pulmonary issue developing.

To further elucidate these findings, the team ordered a chest X-ray and additional blood tests. The chest X-ray indicated a slight reaccumulation of fluid in the lower lung fields. Concurrently, the laboratory results showed a hemoglobin level that had dropped to 8.5 g/dL, raising concerns about anemia, potentially exacerbated by the dialysis process. The patient's serum potassium had stabilized at 4.8 mEq/L; however, the calcium level remained low at 7.8 mg/dL, despite supplementation. These findings prompted consideration of the need for transfusion and reevaluation of the dialysis prescription to better manage fluid and electrolyte shifts.

In response to these developments, the healthcare team decided to implement a more comprehensive management plan. This included increasing the frequency of hemoglobin monitoring, reassessing the patient's nutrition and iron supplementation status, and adjusting the dialysis to allow for more gradual fluid removal. The team also planned for a meeting with the nephrology and pulmonology specialists to discuss potential adjustments in treatment strategy. The patient's family was informed of these changes, emphasizing the importance of vigilant monitoring and the collaborative approach being taken to address the evolving complications. This integrated strategy aimed to stabilize the patient's condition, mitigate the risk of further pulmonary compromise, and support recovery of renal function.